会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 스코폴레틴으로 이루어진 염증 치료용 약제 조성물
    • 用于治疗包含SCOPOLETIN的炎症的药物组合物
    • KR1020010054745A
    • 2001-07-02
    • KR1019990055696
    • 1999-12-08
    • 정헌택강태현배현옥김윤철
    • 정헌택배현옥김윤철강태현
    • A61K36/282A61P29/00
    • PURPOSE: A pharmaceutical composition useful for treatment of an inflammatory disease and containing scopoletin extracted from Artemisia capillaris Thunb as an effective component is provided, which is low in toxicity as compared to conventional steroid inflammation treating agents and safe. CONSTITUTION: This pharmaceutical composition contains scopoletin extracted from Artemisia capillaris Thunb as an effective component. The effective daily dose of the composition is 100 microgram per kg as a health adult. The composition can be used for the treatment of disease and inflammation caused by excess production of nitrogen monoxide by inhibiting the production of nitrogen monoxide of leucocytoid.
    • 目的:提供一种药物组合物,用于治疗炎症性疾病,并含有从艾蒿提取的青蒿素作为有效成分,与常规类固醇炎症治疗剂相比,毒性低,安全。 构成:该药物组合物含有从青蒿提取的青蒿素作为有效成分。 作为健康成人,组合物的有效日剂量为100微克/ kg。 该组合物可用于通过抑制白细胞的一氧化氮的产生来治疗由过量产生一氧化氮引起的疾病和炎症。
    • 6. 发明公开
    • 디메톡시커큐민을 함유하는 혈관재협착 방지용 조성물
    • 含有去甲氧草胺的药物组合物以防止遗留
    • KR1020080019787A
    • 2008-03-05
    • KR1020060082124
    • 2006-08-29
    • 정헌택
    • 정헌택배현옥김윤철
    • A61K31/12A61P9/10
    • A pharmaceutical composition containing demethoxycurcumin is provided to inhibit predifferentiation of vascular smooth muscle cells by the expression of heme oxygenase-1(HO-1), and block the neointimal hyperplasia, so that it is useful for prevention of restenosis. A pharmaceutical composition for preventing restenosis contains demethoxycurcumin isolated from Curcuma longa L. and represented by the formula(1) which induces expression of heme oxygenase-1(HO-1), and is prepared by mixing demethoxycurcumin with pluronic gel consisting of water and gel, and applied to the damaged blood vessel by coating the blood vessel in the thickness of 0.1-1 mm or inserting a demethoxycurcumin-coated stent to a restenosis site. Further, the pharmaceutical composition is made by mixing 40-60% of pluronic gel 0.1ml and 1Î10^(-5) to 1Î10^(-4) of dimethoxycurcumin.
    • 提供含有脱甲氧基姜黄素的药物组合物,通过血红素加氧酶-1(HO-1)的表达抑制血管平滑肌细胞的分化,阻断新生内膜增生,从而有助于预防再狭窄。 用于预防再狭窄的药物组合物含有从姜黄分离得到的脱甲氧基姜黄素,由式(1)表示,其诱导血红素加氧酶-1(HO-1)的表达,并且通过将脱甲氧基姜黄素与由水和凝胶组成的普流胶 并通过以0.1-1mm的厚度涂布血管或将去甲氧基姜黄素涂覆的支架插入再狭窄部位而应用于损伤的血管。 此外,药物组合物通过将40-60%的pluronic凝胶0.1ml和1μ10^( - 5)混合成1〜10 ^( - 4)的二甲氧基姜黄素而制成。
    • 7. 发明授权
    • 자동 세척기능이 구비된 고액분리장치
    • KR102202951B1
    • 2021-01-14
    • KR1020200099219
    • 2020-08-07
    • 김윤철박성신
    • 김경식김윤철박성신
    • C02F11/125B04B1/20B30B9/12B08B3/02
    • 본발명은고액분리장치에관한것으로, 더욱상세하게는개구부를통해유입된함수슬러지에서고형물과오수를분리하여배출하는본체; 상기본체의선단측에배치되어상기본체로부터케이크형태로배출되는고형물을케이크수거부로전달하는케이크배출부; 및상기본체에서배출되는오수를저장하고, 저장된오수를상기개구부로토출시켜상기본체내측을세척하도록구성되는세척수단;을포함하여음식물쓰레기및 오폐수등에포함된함수율이높은슬러지를처리하여오수와고형물로각각분리배출함에있어고형물에포함된함수율을크게낮출수 있어슬러지의고액분리처리량을늘려주고, 또한, 배출된오수를재이용하여장치내부를자동세척하도록구성함으로써, 장치를위생적으로운용할수 있으며, 아울러고형물과오수가분리되는여과망역시자동으로세척하도록구성하여여과망의막힘에의해고액분리처리능력이저하되는것을방지함으로써장치효율을항상최상의상태로유지시킬수 있는장점이있는자동세척기능이구비된고액분리장치에관한것이다.